Join
Live feed
·
PRReleasevia Quantisnow
Intensity Therapeutics Inc. logo

Intensity Therapeutics Strengthens IP Portfolio with Issuance of New Patent in the US

ByQuantisnow·Wall Street's wire, on your screen.
INTS· Intensity Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INTS (Intensity Therapeutics Inc.) and more on Quantisnow.